OAB0702 Overlapping significant life events are associated with HIV viral non-suppression among youth in clinics in rural East AfricaOral Abstract SessionB51
OAB0703 Improving pediatric index testing: Data from 12 PEPFAR-supported countries in sub-Saharan AfricaOral Abstract SessionB47
OAB0704 Biomarker assessment of infant adherence to isoniazid prophylaxis in a primary TB infection prevention trial in KenyaOral Abstract SessionB55
OAB0705 Rates of cervical lesions by age and previous screening status and enhancing treatment among women living with HIV (WLHIV) in sub-Saharan Africa within the Go Further partnershipOral Abstract SessionB14
OAB0706 Plasma exposure-viral load response analysis for dolutegravir in children with HIV-1: Results from IMPAACT P1093Oral Abstract SessionB48
OABLB0101 Safety, pharmacokinetics and efficacy of low-dose E/C/F/TAF in virologically suppressed children '¥2 years old living with HIVOral Abstract SessionB50
OABLB0102 Clinical outcomes by HIV serostatus, CD4 count, and viral suppression among people hospitalized with COVID-19 in the Bronx, New YorkOral Abstract SessionB69
OABLB0103 The predicted risk of adverse pregnancy outcomes from treatment-induced obesity in the ADVANCE trialOral Abstract SessionB44
OABLB0104 Immunologic characteristics of acute COVID-19 in people with HIVOral Abstract SessionB69
OABLB0105 Faster virological suppression with dolutegravir versus efavirenz in pregnancy does not lower the risk of HIV mother-to-child-transmission: A meta-analysis of 5 clinical trials in 1074 pregnant womenOral Abstract SessionB44
seek-warrow-warrow-eseek-e101 - 110 of 2297 items